SigmaScreening
SigmaScreening has developed a mammography device that reduces pain and improves diagnostic accuracy. Founded by Amsterdam UMC professors, the company aims to enhance breast cancer detection with their patented technology. SigmaScreening has licensed their technology to Teledyne, who continue development of the device.
Rsouth Antibodies
Rsouth Antibodies has developed a therapeutic antibody for Respiratory Syncytial Virus (RSV) that has been licensed to MedImmune (now AstraZeneca). AstraZeneca has finalized clinical validation and obtained regulatory approval for this antibody that is now marketed by Sanofi as Nirsevimab for prevention of RSV in infants. Since RSV infection have been on the rise again […]
Primagen
Primagen Holding focuses on developing molecular diagnostic tests and investing in bio- and medtech startups. The company generates revenues through the licensing of their diagnostics technology. Primagen Holding’s portfolio includes investments in PulseCath and Akkolens International.
Phlox Therapeutics
Phlox Therapeutics uses smart RNA designs to target multiple Lamin A/C mutations, offering therapies for rare genetic cardiomyopathies. Their constructs, developed by the group of Amsterdam UMC Professor Yigal Pinto, show promising therapeutic effects in patient-derived cardiomyocytes. Phlox Therapeutics aims to expand their technology to other treatment-resistant cardiomyopathies.
PacingCure
PacingCure is pioneering gene therapy solutions to cure heart conditions that results in pacing issues. The company focuses on developing biological pacemakers for patients who cannot use conventional electronic pacemaker devices. Their research explores various transgenes and delivery systems to modulate heart pacing. PacingCure is dedicated to advancing cardiac care through innovative gene therapy.
Kling Biotherapeutics
Discovering antibody-based therapeutics, Kling Biotherapeutics targets cancer and infectious diseases. Their platform leverages patient immune repertoires to identify novel therapeutic targets. Kling Biotherapeutics has a rich pipeline of antibodies for oncology and infectious disease applications in clinical and preclinical development.
InSteps
Providing in-silico modeling for stroke treatment, InSteps develops a platform to simulate various stroke scenarios. Their technology aids in the development of thrombectomy devices and optimizes clinical trials, giving more patients access to life-saving treatments. The company is committed to enhancing stroke care through advanced simulation technology.
Inreda Diabetic
Developing a bi-hormonal artificial pancreas, Inreda Diabetic offers a closed-loop system for diabetes management. Their device automates insulin and glucagon administration, drastically reducing the burden on patients compared to classic single-hormone pumps. Inreda Diabetic’s technology aims to improve blood glucose control and quality of life for diabetes patients.
ikHerstel
Enhancing post-surgery recovery, ikHerstel offers an e-Health app that provides personalized recovery plans. Their app, based on research from Amsterdam UMC, helps patients recover faster and more effectively. ikHerstel has received significant recognition and funding for their innovative approach. The company is committed to transforming post-operative care through digital health solutions.
Haermonics
Innovating post-surgery care, Haermonics develops a device to flush and clean the pericardial space, preventing blood-related complications after open-heart surgery. Their technology reduces the risk of blood clots and subsequent operations. The company is dedicated to improving surgical outcomes through advanced medical devices.